PRPH News and Press, ProPhase Labs Inc. From 08/12/25

A look at the top 10 most actives in the United States Tilray Brands Inc. (TLRY) rose 3.3% to $0.9505 on volume of 287,286,194 shares ProPhase Labs Inc. (PRPH) rose 25.7% to $0.354 on volume of 271,355,529 shares BigBear.ai Inc. (BBAI) fell 15.8% to $5.97 on volume of 236,791,375 shares 1...

A look at the top 10 most actives in the United States ProPhase Labs Inc. (PRPH) rose 40.3% to $0.3951 on volume of 143,892,566 shares TNF Pharmaceuticals Inc. (TNFA) rose 9.8% to $0.1207 on volume of 119,260,323 shares Tilray Brands Inc. (TLRY) rose 17.3% to $1.079 on volume of 88,003,434 ...

U.S. Patent No. 12379378-B2 protects biomarker-driven systems and methods to assess progression risk in Barrett’s esophagus and esophageal adenocarcinoma; issuance follows the successful BE-Smart ™ test validation (>95% technical success) and, together with BE-Smart&#...

UNIONDALE, NY, Aug. 11, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ: PRPH), (the “Company” or “ProPhase”), a next generation biotech, genomics and consumer products company, announced today that they will be presenting second quarter 2025 financial results on...

Proxy Sets Company on a Path to Attract the Optimal Crypto Treasury Strategy Increase in Authorized Shares to 1 Billion Would Position the Company to Attract Industry-Leading Market Participants and High-Value Crypto Treasury Transactions UNIONDALE, NY, July 29, 2025 (GLOBE NEWSWI...

Financing provides bridge to multiple potentially significant liquidity events and crypto strategies UNIONDALE, NY, July 23, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), (the "Company" or "ProPhase") today announced the closing of a private placement financing with two i...

UNIONDALE, NY, July 21, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), (the “Company” or “ProPhase”) a next generation biotech, genomics and consumer products company, today announced that its Board of Directors has unanimously authorized the Company&#x...

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – Baystreet.ca News Commentary – The current landscape of oncology is a mixed bag of results, with optimism coming from a decrease in US cancer deaths, coupled with pessimism as global cases are expect...

2025-06-26 08:36:36 ET More on ProPhase Labs ProPhase Labs, Inc. (PRPH) Q1 2025 Earnings Call Transcript ProPhase Labs, Inc. (PRPH) Q4 2024 Earnings Call Transcript ProPhase Labs, Inc. 2024 Q4 - Results - Earnings Call Presentation ProPhase Labs FY 2024 Earni...

UNIONDALE, NY, June 26, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ: PRPH), (the “Company” or “ProPhase”) a next generation biotech, genomics and consumer products company, today announced that it has received an extension of 180 calendar days (the "Extension...